RxDoctor Payments Data

Evan Russell, DO

Hospitalist · North Kansas City, MONPI 1902211808

Payments from drug & device makers

What this record shows

That places this record below the midpoint for hospitalist clinicians in MO, where the typical reported total is $41.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$632,264in research payments, 2019–2025

Across 65 payments — averaging $9727.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$265K
  • Acella Pharmaceuticals, LLC$185K
  • Sekisui Diagnostics LLC$129K
  • Astrazeneca UK Limited$42K
  • Avion Pharmaceuticals$12K

How this compares

$0 in reported general payments places this provider in the 30th percentile of 712 hospitalist providers in Missouri.

See all hospitalist providers in Missouri

Medicare billing

Part B allowed, 2024
$112,058
Medicare patients
341
Services billed
1,094

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$193
Cefdinir20$170
Prednisone30$68
Amlodipine Besylate13$26

Paid to pharmacies, not to this prescriber.

Other hospitalist in North Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →